Fibrovascular Changes Misdiagnosed as Cytomegalovirus Retinitis Reactivation in a Patient with Immune Recovery

Robinson, Michael R.; Csaky, Karl G.; Lee, Susan S.; Masur, Henry; Polis, Michael A.
January 2004
Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p139
Academic Journal
A patient with human immunodeficiency virus infection and cytomegalovirus (CMV) retinitis developed immune recovery uveitis as a result of receipt of highly active antiretroviral therapy. Fibrovascular changes occurred in the CMV retinitis scar, were misdiagnosed as CMV retinitis reactivation, and were treated with anti-CMV medication. Fibrovascular membranes can be misdiagnosed as reactivated CMV retinitis, and a proper diagnosis is essential to avoid unnecessary therapy with potentially toxic antiviral medications.


Related Articles

  • cidofovir.  // Davis's Drug Guide for Nurses, 10th edition;2007, p281 

    The article presents a nursing guide for the antiviral drug cidofovir. The drug is used for the management of cytomegalovirus retinitis in HIV-infected patients. The article offers information on the pharmacokinetics of the drug, including metabolism and excretion. Among its adverse reactions...

  • Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study. Manuel, Oriol; Husain, Shahid; Kumar, Deepali; Zayas, Carlos; Mawhorter, Steve; Levi, Marilyn E.; Kalpoe, Jayant; Lisboa, Luiz; Ely, Leticia; Kaul, Daniel R.; Schwartz, Brian S.; Morris, Michele I.; Ison, Michael G.; Yen-Lieberman, Belinda; Sebastian, Anthony; Assi, Maha; Humar, Atul // Clinical Infectious Diseases;Mar2013, Vol. 56 Issue 6, p817 

    In high-risk solid-organ transplant recipients receiving antiviral prophylaxis, the measurement of specific cell-mediated immunity using the Quantiferon assay appropriately stratified the individual risk of developing subsequent cytomegalovirus disease.Background. Cytomegalovirus (CMV) disease...

  • Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients. Kim, Jong Man; Kwon, Choon Hyuck David; Joh, Jae-Won; Ha, Young Eun; Sinn, Dong Hyun; Choi, Gyu-Seong; Peck, Kyong Ran; Lee, Suk-Koo // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Objectives: Cytomegalovirus (CMV) infections in liver transplant recipients are common and result in significant morbidity and mortality. Intravenous ganciclovir or oral valganciclovir are the standard treatment for CMV infection. The present study investigates the efficacy of oral...

  • Cytomegalovirus (CMV) Blood DNA Load, CMV Retinitis Progression, and Occurrence of Resistant CMV in Patients with CMV Retinitis. Jabs, Douglas A.; Martin, Barbara K.; Forman, Michael S.; Ricks, Michelle O. // Journal of Infectious Diseases;8/15/2005, Vol. 192 Issue 4, p640 

    Background. The amount of cytomegalovirus (CMV) DNA in the blood (CMV load) may be a marker for detection of resistant CMV. Methods. A total of 165 patients with AIDS and CMV retinitis had CMV load measurements (plasma and leukocyte) and cultures performed every 3 months; these measurements were...

  • Clinical and radiological deterioration in a patient with AIDS. De Backer, A. I.; MortelĂ©, K. J.; Bomans, P.; De Keulenaer, B. L.; Vanschoubroeck, I. J.; Kockx, M. M.; MortelĂ©, K J // European Radiology;Nov2005, Vol. 15 Issue 11, p2264 

    Paradoxical clinical deterioration of miliary tuberculosis, characterized by pulmonary and abdominal manifestations, is reported in a patient with the acquired immunodeficiency syndrome, after initiation of treatment with highly active antiretroviral therapy. Paradoxical reaction was attributed...

  • The Absence of CD4+ T Cell Count Recovery Despite Receipt of Virologically Suppressive Highly Active Antiretroviral Therapy: Clinical Risk, Immunological Gaps, and Therapeutic Options. Gazzola, Lidia; Tincati, Camilla; Bellistri, Giusi Maria; Monforte, Antonella d'Arminio; Marchetti, Giulia // Clinical Infectious Diseases;2/1/2009, Vol. 48 Issue 3, p328 

    Up to 30% of human immunodeficiency virus (HIV)-infected patients who are receiving long-term highly active antiretroviral therapy do not exhibit a marked increase in the CD4+ T cell count, despite achieving complete suppression of the HIV load. These patients are referred to as "immunological...

  • Whole Transcriptome Sequencing Enables Discovery and Analysis of Viruses in Archived Primary Central Nervous System Lymphomas. DeBoever, Christopher; Reid, Erin G.; Smith, Erin N.; Wang, Xiaoyun; Dumaop, Wilmar; Harismendy, Olivier; Carson, Dennis; Richman, Douglas; Masliah, Eliezer; Frazer, Kelly A. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Primary central nervous system lymphomas (PCNSL) have a dramatically increased prevalence among persons living with AIDS and are known to be associated with human Epstein Barr virus (EBV) infection. Previous work suggests that in some cases, co-infection with other viruses may be important for...

  • Dynamics of Cytomegalovirus (CMV)--Specific T Cells in HIV-1--Infected Individuals Progressing to AIDS with CMV End-Organ Disease. Bronke, Corine; Palmer, Nanette M.; Jansen, Christine A.; Westerlaken, Geertje H. A.; Polstra, Abeltje M.; Reiss, Peter; Bakker, Marqreet; Miedema, Frank; Tesselaar, Kiki; Van Baarle, Debbie // Journal of Infectious Diseases;3/15/2005, Vol. 191 Issue 6, p873 

    Background. Since cytomegalovirus (CMV) infection can cause serious clinical complications in immunocompromised individuals, we assessed cellular immune requirements for protection against CMV end-organ disease (CMV-EOD) in human immunodeficiency virus type 1 (HIV-1) infection. Methods....

  • Maintaining Antiretroviral Therapy Reduces the Risk of AIDS-Defining Events in Patients with Uncontrolled Viral Replication and Profound Immunodeficiency. Kousignian, Isabelle; AbgraII, Sophie; Grabar, Sophie; Mahamat, Aba; Teicher, Elina; Rouveix, Elisabeth; Costagliola, Dominique // Clinical Infectious Diseases;1/15/2008, Vol. 46 Issue 2, p296 

    Background. The benefits of continuing antiretroviral therapy are questionable in human immunodeficiency virus (HIV) type 1-infected patients with profound immunodeficiency and multiple treatment failure due to viral resistance. Methods. From the French Hospital Database on HIV, we selected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics